Journals / Türk Biyokimya Dergisi / 2013 / Cilt: 38 - Sayı: 3

Sequence Variant in the LPIN1 gene in Patients with DEDE Metabolic Syndrome

Metabolik Sendrom Hastalarında LPIN1 Geni Dizi Varyantı

Pages
280–285
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Any important sequence variant was not detected in exons 2, 4, 5 and 14 in the LPIN1 gene in MetS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Metabolic syndrome (MetS) is a complex disease characterized by insulin resistance, abdominal obesity, hyperglycemia, hypertension, hypertriglyceridemia and low HDL-cholesterol level.
📊
Key Findings & Data:The aim of the study was to evaluate the sequence variations in the LPIN1 gene in MetS.
💡
Conclusion & Impact:Conclusion: Any important sequence variant was not detected in exons 2, 4, 5 and 14 in the LPIN1 gene in MetS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Metabolic syndrome (MetS) is a complex disease characterized by insulin resistance, abdominal obesity, hyperglycemia, hypertension, hypertriglyceridemia and low HDL-cholesterol level. The aim of the study was to evaluate the sequence variations in the LPIN1 gene in MetS. This gene codes lipin-1 protein which functions as Mg-dependent phosphatidic phosphatase enzyme and transcriptional coactivator. Material and Methods: The study groups included 73 MetS (19 M/54 F) and 56 non-MetS (16 M/ 40 F). Sequence variation in exons 2, 4, 5 and 14 of the LPIN1 gene were investigated by DNA sequencing method. Results: c.696 G>C variant (p.S232S) in exon 5 was observed in only one women with MetS. But this variation is not important because of coding same amino acid. Conclusion: Any important sequence variant was not detected in exons 2, 4, 5 and 14 in the LPIN1 gene in MetS.

Özet

Amaç: Metabolik sendrom (MetS) insülin resistansı, abdominal obezite, hiperglisemi, hipertansiyon, hipertrigliseridemi ve düşük HDL kolesterol seviyeleri ile karakterize kompleks bir hastalıktır. Bu çalışmanın amacı, MetS'de LPIN1 geni dizi değişikliklerini değerlendirmekti. Bu gen, Mg-bağımlı fosfatidik asit fosfataz enzimi ve transkripsiyon koaktivatörü olarak fonksiyon gören lipin 1 proteinini kodlamaktadır. Gereç ve Yöntemler: Çalışma grubu, 73 MetS (19 E/54 K) olan ve 56 MetS olmayan (16 E/ 40 K) kişiden oluşturuldu. LPIN1 geninde ekzon 2, 4, 5 ve 14'de dizi varyasyonu, DNA dizi analizi yöntemi ile araştırıldı. Bulgular: Sadece bir bayan hastada ekzon 5'de c.696 G>C (p. S232S) değişimi görüldü. Ancak aynı amino aside denk geldiği için bu değişim önemli değildir. Sonuçlar: MetS da LPIN1 ekzon 2, 4, 5 ve 14'de önemli bir dizi değişimi saptanmadı.

🔖

Cite This Article

TURAN, İ., BARLAK, Y., ALİYAZICIOĞLU, R., KURAL, B. V., YÜCESAN, F. B., EREM, C., DEĞER, O. (2022). Sequence Variant in the LPIN1 gene in Patients with DEDE Metabolic Syndrome. Türk Biyokimya Dergisi, Cilt: 38 - Sayı: 3, 280–285. https://ajindex.com/articles/621281

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Aguilera CM, Gil-Campos M, Cañete R, Gil A. Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome. Clin Sci (Lond) 2008; 114(3):183-93
  2. Alshehri AM. Metabolic syndrome and cardiovascular risk. J Family Community Med 2010; 17(2):73-8
  3. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26(3):575-81
  4. Bee YT Jr, Haresh KK, Rajibans S. Prevalence of Metabolic Syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and Modified World Health Organization Definitions. Malays J Nutr 2008; 14(1):65-77
  5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004 27; 109(3):433-8
  6. Han GS, Carman GM. Characterization of the human LPIN1- encoded phosphatidate phosphatase isoforms. J Biol Chem 2010; 285(19):14628-38
  7. Burgdorf C, Hänsel L, Heidbreder M, Jöhren O, Schütte F, et al. Suppression of cardiac phosphatidate phosphohydrolase 1 activity and lipin mRNA expression in Zucker diabetic fatty rats and humans with type 2 diabetes mellitus. Biochem Biophys Res Commun 2009; 390(1):165-70
  8. Reue K. The Lipin Family: Mutations and Metabolism. Curr Opin Lipidol 2009; 20(3): 165-70
  9. Reue K, Dwyer JR. Lipin proteins and metabolic homeostasis. J Lipid Res. 2009; 50 Suppl: S109-14
  10. Ishimoto K. Lipin 1 in lipid metabolism. Yakugaku Zasshi 2011; 131(8):1189-94
  11. Reue K, Zhang P. The lipin protein family: dual roles in lipid biosynthesis and gene expression. FEBS Lett 2008; 582(1):90-6
  12. González CR, Novelle MG, Caminos JE, Vázquez MJ, Luque RM, et al. Regulation of lipin1 by nutritional status, adiponectin, sex and pituitary function in rat white adipose tissue. Physiol Behav 2012; 105(3):777-83
  13. Zhang P, O'Loughlin L, Brindley DN, Reue K. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J Lipid Res 2008; 49(7):1519-28
  14. Bou Khalil M, Blais A, Figeys D, Yao Z. Lipin - The bridge between hepatic glycerolipid biosynthesis and lipoprotein metabolism. Biochim Biophys Acta 2010; 1801(12):1249-59
  15. Harris TE, Finck BN. Dual function lipin proteins and glycerolipid metabolism. Trends